Back to Cerity Partners LLC Cerity Partners LLC

SAVASAVA

Showing 3 of 4 quarters

Position history for Cerity Partners LLCCerity Partners LLC's holdings in FILANA THERAPEUTICS INC

No. Cerity Partners exited its SAVA (Filana Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 35,364 shares worth $88,440. Cerity Partners first reported SAVA in Q2 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1M

Total Shares Change

-35,354

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$1.50
0
2024-Q4
Increased
35,364
+0.0%
$88,4400.0%$2.36
21
2024-Q3
Increased
35,354
+0.3%
$1M0.0%$29.43
25

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used